Welcome To The Stereotaxis HUB On AGORACOM
Improving Life With Robotic Precision and Safety
Stereotaxis is proud that physicians worldwide use its technologies every day to achieve exceptional clinical outcomes without compromising safety, enabling them to confidently treat areas of the heart unreachable or potentially unsafe with manual techniques or alternative technologies.
Stereotaxis' goal is to make complex cardiac interventions simpler, safer, and more effective, everywhere they are performed. It aims to achieve this with computer controlled, magnetic navigation technology that guides catheters and other devices through the cardiovascular system with great precision and safety, and with integrated information systems and advanced networking tools that enable collaboration, remote consultation and training among clinicians anywhere they have access to the internet. Stereotaxis pioneered magnetic navigation for the electrophysiology lab. Since 2004, clinicians have repeatedly demonstrated the value of its remote magnetic navigation technology in the treatment of cardiac arrhythmias over a very large number of cases. Stereotaxis' technology has also been used across a broad range of compelling applications in interventional cardiology, underscoring its value as a platform technology for all types of complex interventional procedures where gentle, precise navigation might enhance patient care and improve outcomes. The world's leading specialists in electrophysiology ablation, cardiac resynchronization therapy and interventional cardiology have endorsed Stereotaxis' technologies.
Community hospitals, major research institutions and commercial, high-volume healthcare organizations in more than 27 countries have installed Stereotaxis' magnetic navigation system. With the diverse group of clinicians that now routinely uses Stereotaxis technology, the company is proud that it is widely recognized for its peerless safety profile: 99.9% of procedures performed with the magnetic navigation system have been completed without major complication. Stereotaxis is equally proud that its technologies have limited x-ray exposure for the physician and patient alike, and have allowed physicians to exchange the heavy lead suits required during manual procedures for a comprehensive, user-friendly digital interface through which the procedure can be conducted, from the control room.
Stereotaxis provides comprehensive training to the physicians and other healthcare providers who use its products. This dynamic process often inspires the company to develop new devices, software, and procedure solutions to further enhance the practice of interventional medicine. Clinicians using the advanced archiving and networking capabilities of Odyssey, for instance, are positioned to significantly accelerate the advancement of interventional medicine worldwide.
The company designs, manufactures and markets its own products, and works closely with Siemens, Phillips and other important, global medical device manufacturers to integrate their EP and cath lab imaging technologies with Stereotaxis systems. In addition, the magnetically-enabled ablation and mapping catheters used with the Magnetic Navigation System is manufactured and marketed by Biosense Webster, Inc., a Johnson & Johnson company. The appropriate regulatory agencies in the United States, European Union and other countries have cleared and approved the key Stereotaxis technologies, and they are available throughout the world.